Does vitamin D help regulate immunity in Hashimoto’s thyroiditis?

Vitamin D has established immunoregulatory actions, and low 25-hydroxyvitamin D [25(OH)D] is frequently observed in people with established Hashimoto’s thyroiditis. The evidence is strongest for immune mechanisms and for an association with disease presence—not for a consistent relationship with the magnitude of thyroid autoantibody titers.

Clinical association

• A meta-analysis of 25 studies (2,695 Hashimoto’s cases; 2,263 controls) found lower 25(OH)D in Hashimoto’s thyroiditis (Cohen’s d −0.62, 95% CI −0.89 to −0.34) and higher odds of deficiency, defined as <20 ng/mL (OR 3.21, 95% CI 1.94–5.30). A later meta-analysis estimated a −6.05 ng/mL mean difference.
• These are predominantly cross-sectional/case–control findings. High heterogeneity (I²=91%), inconsistent adjustment for season, adiposity, sun exposure, supplementation, and disease severity, and a null adjusted study of 461 cases mean the association does not establish cause, direction, or a preventive treatment role.

Immune mechanisms

• Immune cells can locally convert 25(OH)D to calcitriol, which signals through the vitamin D receptor (VDR). In monocytes, this supports antimicrobial programs including cathelicidin and β-defensin 2, with associated autophagy/phagolysosomal activity.
• In dendritic cells, calcitriol reduces maturation, MHC/costimulatory expression, IL-12 production, and antigen-specific T-cell activation, while increasing IL-10—features of a more tolerogenic phenotype.
• VDR signaling can also favor regulatory T-cell/IL-10 responses and suppress B-cell proliferation, plasma-cell differentiation, and antibody secretion. These effects are context- and dose-dependent and do not prove clinical autoimmune benefit.

Thyroid autoantibodies

• An inverse relation with TPOAb or TgAb is biologically credible but clinically inconsistent. Studies of 461 patients with Hashimoto’s and 5,230 participants found no significant correlation between 25(OH)D and antibody titers.

Bottom line

• Vitamin D is an important immune modulator, and low vitamin D status is a moderately supported correlate of prevalent Hashimoto’s thyroiditis. Higher thyroid autoantibody levels are not a reliably established correlate; vitamin D status alone should not be interpreted as a cause of Hashimoto’s or a proven treatment target.